Trial Profile
Vaccinations in the Immunocompromised Population: Paramount and Paradox
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 29 Jul 2022
Price :
$35
*
At a glance
- Drugs Hepatitis A vaccine (Primary) ; Pneumococcal 13-valent CRM197 vaccine conjugate (Primary) ; Pneumococcal vaccine (Primary)
- Indications Hepatitis A; Pneumococcal infections
- Focus Pharmacodynamics
- Acronyms VIPPP
- 01 Aug 2022 Results (n=120)published in the International Journal of Antimicrobial Agents
- 13 Aug 2018 New trial record